Ayodeji A. Agbowuro

Dr. Ayodeji A. Agbowuro

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 January 2025 in Drug Development Research
Verified
Journal Article
Closed access
LDLaura D'ALessio‐Sands
Laura D'ALessio‐Sands
JGJoshua Gaynier
Joshua Gaynier
VMVictoria Michel‐Milian
Victoria Michel‐Milian
AAAyodeji A. Agbowuro
Ayodeji A. Agbowuro
CBChristopher M. Brackett
Christopher M. Brackett

26 July 2026 in Brain Sciences
Verified
Journal Article
Open access
PDF file
SHStan Heath
Stan Heath
MRMadeline Ruzicka
Madeline Ruzicka
TMTaylor McLoon
Taylor McLoon
DGDaya Gupta
Daya Gupta
OEOnyinyechi Emeri
Onyinyechi Emeri
AAAyodeji A. Agbowuro
Ayodeji A. Agbowuro
The N-methyl-D-aspartate receptor (NMDAR) is an ionotropic glutamate receptor widely expressed in the CNS and in peripheral tissues where it mediates crucial physiological functions and its dysregulation has been linked to a host of neurological and psychiatric disorders including Alzheimer’s disease, schizophrenia, epilepsy, and chronic pain. This work highlights the therapeutic potential in targeting the NMDAR in these disease states by providing a holistic analysis of the existing literature focused on the molecular role of the receptor in applicable disease conditions. While several drugs targeting the NMDAR have been approved for clinical use, many more are in clinical and preclinical development. A significant part of this review assesses the chemical and pharmacological attributes of these molecules and provides a prognostic perspective for their use.